Optimization of cyclosporine therapy with new therapeutic drug monitoring strategies: Report from the International Neoral® TDM Advisory Consensus Meeting (Vancouver, November 1997)

Transplantation Proceedings

Volumn 30, Issue 5, 1998, Pages 1645-1649

  Keown, P ^a   Kahan, B D ^b   Johnston, A ^c   Levy, G ^d   Dunn S P ^e   Cittero, F ^f   Grino, J M ^g   Hoyer, P F ^h,j   Wolf, P ⁱ   Halloran, P F ^h,j  

^a VANCOUVER GENERAL HOSPITAL   (Canada)

^b UNIVERSITY OF TEXAS   (United States)

^c ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

^d UNIVERSITY OF TORONTO   (Canada)

^e ST CHRISTOPHER'S HOSPITAL FOR CHILDREN   (United States)

^f CATHOLIC UNIVERSITY   (Italy)

^g HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

^h Kinderklinik   (Germany)

ⁱ HÔPITAL DE HAUTEPIERRE   (France)

^j UNIVERSITY OF ALBERTA   (Canada)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN A;

ALGORITHM; AREA UNDER THE CURVE; CLINICAL TRIAL; CONFERENCE PAPER; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG EXPOSURE; DRUG FORMULATION; DRUG MONITORING; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; ORAL DRUG ADMINISTRATION; PRACTICE GUIDELINE; PRIORITY JOURNAL; RECIPIENT; RISK FACTOR; SIDE EFFECT;

ADULT; ALGORITHMS; CYCLOSPORINE; DOSAGE FORMS; DRUG MONITORING; GRAFT REJECTION; HUMANS; TRANSPLANTATION IMMUNOLOGY;

EID: 13144279333     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0041-1345(98)00375-3     Document Type: Conference Paper

References (31)

1. Kahan BD: N Engl J Med 321:1725, 1989
2. Kahan BD, Shaw LM, Holt D: Clin Chem 36:1510, 1990
3. Lindholm A, Kahan BD: Clin Pharmacol Ther 54:205, 1993
4. Schroeder TJ, Hariharin S, First MR: Transplant Proc 26: 2787, 1994
5. Kahan BD, Welsh M, Schoenberg L, et al: Transplantation 62:599, 1996
6. Mueller EA, Kovarik JM, Van Bree JB, et al: Transplantation 57:1178, 1994
7. Kahan BD, Dunn J, Fitts C, et al: Transplantation 59:505, 1995
8. Keown P, Landsberg D, Halloran P, et al: Transplantation 62:1744, 1996
9. Barone G, Chang CT, Choc MG, et al: Transplantation 61:875, 1996
10. Hemming AW, Greig PD, Cattral MS, et al: Transplantation 62:1798, 1996
11. Trull AK, Steel L, Sharples L, et al: J Heart Lung Transplant 16:45, 1997
12. Cooney GF, Jeevanandam V, Choudhury S, et al: Transplant Proc 30:(this issue), 1998
13. Lodge JPA, Pollard SG: Transplant Proc 29:272, 1997
14. Pollard SG, Lodge JPA: Transplant Proc 28:2214, 1996
15. Mirza DF, et al: The Lancet 349:701, 1997
16. Amante AJ, Kahan BD: Transplant Proc 28:2162, 1996
17. Johnston A, Kovarik JM, Mueller EA, et al: Transplant Int 9:S305, 1996
18. Canadian Liver Transplant Study. 16th Annual Meeting ASTP. (Abstr #72), 1997
19. Batiuk TD, Pazderka F, Halloran PF: Transplantation 59: 1400, 1995
20. Batiuk TD, Urmson J, Vincent D, et al: Transplantation 61:1618, 1996
21. Grevel J, Kahan BD: Ther Drug Monit 13:89, 1991
22. Keown PA, et al: Transplant Proc 28:2147, 1996
23. Johnston A, Sketris I, Marsden JT, et al: Transplant Proc 22:1345, 1990
24. Grevel J, Kahan BD: Clin Chemistry 37:1905, 1991
25. Kahan BD, Welsh M, Rutzky LP: Ther Drug Monit 17:621, 1995
26. Gaspari F, Anedda F, Signorini O, et al: J Am Soc Nephrol 8:647, 1997
27. Dunn SP, Cooney GF, Kulinsky A, et al: Transplantation 63:1762, 1997
28. Hoyer PF, Boekenkamp A, Vester U, et al: Transplant Proc 28:2259, 1996
29. Portman R. Transplant Immunol Lett 13:3, 1998
30. Cooney GF, Lum BL, Meligeni JA, et al: Transplant Proc 28:2270, 1996
31. Oellerich M, Armstrong VW, Kahan BD, et al: Ther Drug Monit 17:642, 1995